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Abstract 
After years of research on the ability of glass-ceramics in bone regeneration, this family 
of biomaterials has shown revolutionary potentials in a couple of emerging applications such as 
cancer treatment. Although glass-ceramics have not yet reached their actual potential in cancer 
therapy, the relevant research activity is significantly growing in this field. It has been projected 
that this idea and the advent of magnetic bioactive glass-ceramics and mesoporous bioactive 
glasses could result in major future developments in the field of cancer. Undoubtedly, this 
strategy needs further developments to better answer the critical questions essential for the 
clinical usage. This review aims to address the existing research developments on glass-ceramics 
for cancer treatment, starting with the current status and moving to the future advances. 
Keywords: Glass-ceramic; Bioactive glass; Biomaterials; Ferrimagnetism; Hyperthermia; Cancer; 
Magnetite 
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1. Introduction 
Cancer is among one of the most problematic diseases in the medical investigation of our 
time, in which the cells divide uncontrollably and destroy tissues [1]. It is known as a challenging 
illness to treat because of the fact that the existing cure choices are incomplete and, somehow, 
the suitable diagnosis and prognosis are complex [2]. There are many ways to treat cancer 
tumors including surgery, radiotherapy, chemotherapy, and immunotherapy. However, all these 
strategies have shown risky side effects [3-5]. Therefore, much effort has been dedicated to the 
discovery of new methods (noninvasive and minimally invasive) for tumor diagnosis and 
treatment [6]. Hyperthermia therapy is a type of medical treatment to destroy tumors at higher 
temperatures [7].  
It is known that there is always lack of sufficient blood vessels in cancerous tumors. This 
irregular network of vessels is a weak platform for cancerous cells which can be destructed at 
higher temperatures (around 43 °C) due to hemorrhage, stasis and vascular occlusion. This 
elevated temperature is not harmful to the surrounding tissues since the generated heat mostly 
transfers through a normal blood vessel system [8, 9]. There have been several reports on the 
effect of hyperthermia on the pH of tumors. It is known that this process is able to reduce the pH 
value in tumors as a result of vascular occlusion. This pH value reduction can potentially enhance 
the heat sensitivity of tumor cells [7, 10, 11].  
Altogether, hyperthermia can be considered as an alternative cancer treatment process 
[12]. Several methods such as hot water, radiofrequency, infrared rays, ultraviolet rays, and 
microwaves, etc. have been used in hyperthermia treatment [10]. One of the drawbacks of these 
approaches is the difficulty of homogenous heating of the cancer tumor [13]. Among the 
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methods of hyperthermia, magnetic induction technique is an effective approach to heat the 
deep-seated tumors locally and effectively. There is a range of magnetic materials that can be 
used for the destruction of cancer cells, as a result of an external magnetic stimulation. Several 
biomaterials presenting this ability have been developed, among which magnetic glass-ceramics 
have shown promising outcomes [7, 11]. Numerous types and compositions of glass-ceramics 
have been developed and applied with reference to the treatment of different types of cancer 
cells [14, 15]. It is worth mentioning that some classes of magnetic glass-ceramics present anti-
cancer magnetic features as well as bioactivity at the same time. These glass-ceramics are 
implanted near the tumorous bone tissue, without the risk of displacement by biological fluids in 
the body. Under an external altering magnetic field, the aforementioned glass-ceramics start to 
destroy cancer cells through the hyperthermia effect. Additionally, they can directly bond to the 
tumorous bone as a result of bioactivity which can further stimulate bone regeneration [16, 17]. 
Besides magnetic glass-ceramics, mesoporous bioactive glasses have also achieved much 
attention due to their possibility to carry anticancer drugs into the tumor site [18]. 
This review article aims to summarize the pros and cons of glass-ceramics in cancer 
treatment strategy. It is suggested that magnetic bioactive glass-ceramics and mesoporous 
bioactive glasses are able to tackle cancerous cells through different mechanisms of action. 
Apart from heat generating ability of magnetic bioactive glass-ceramics and anti-cancer drug 
delivery capability of mesoporous bioactive glasses, there are a few reports on the spontaneous 
ability of this class of materials for tissue regeneration. On this point, the literature has been 
reviewed to precisely evaluate the existing facts on these synthetic biomaterials.  
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2. Theoretical background and definitions 
2.1. Basic concepts in magnetism  
Magnetism arises from the presence of magnetic dipoles in solid materials. When a 
magnetic material is subjected to a magnetic field, magnetic dipoles having south and north 
poles tend to align themselves with the applied field. Depending on the reaction of magnetic 
dipoles to the external magnetic field, materials can be categorized as diamagnetic, 
paramagnetic, ferromagnetic, antiferromagnetic and ferromagnetic [19]. 
Ferromagnetic and ferrimagnetic materials adopt permanent magnetization after 
subjection to an altering external field. In ferromagnetic materials, regions in which magnetic 
dipoles are more aligned in the same direction with the applied field, start to develop to the 
detriment of less aligned ones, when exposed to an external AC magnetic field. When the 
magnetic field is disconnected, some of the aligned regions still remain and provide permanent 
magnetization. In ferrimagnetic materials, neighboring regions contain antiparallel and unequal 
magnetization which cannot completely compensate for each other. Hence, when the external 
field is disconnected, a net magnetization still remains, giving the material a permanent 
magnetization [19]. 
Among different magnetic materials, ferromagnetic and ferrimagnetic ones are 
extensively utilized for cancer treatment via a magnetic hyperthermia effect. Fig. 1 summarizes 
the in vitro, in vivo and clinical effects of the pulsed magnetic field on cancer cells in a wide 
frequency range [20]. During exposing to a high frequency altering magnetic field, ferromagnetic 
and ferrimagnetic materials produce heat owing to the hysteresis effect of the subjected 
materials. The released heat is greatly influenced by particle size and its distribution. A reduction 
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in particle size with a homogeneous distribution is preferred since they absorb power, more 
effectively[19]. As the temperature is increased from 0 K, the magnetization reduces in both 
ferromagnetic and ferrimagnetic materials [21]. 
 
 
Fig. 1. In magnetic hyperthermia, the generated heat mainly originates from eddy currents and hysteresis losses. 
Altering/pulsed magnetic fields are able to induce small electric currents, in conducting tissues, proportional to the 
applied frequency. At very high frequencies, induced currents may generate a harmful heat in the tissues. At low 
frequencies (0–100 KHz), the released heat in the tissues is somewhat negligible, but the induced currents, if 
sufficiently strong, can possibly stimulate cells through an electrically stimulation mechanism. (partially reprinted 
with the permission from [20]). 
 
 
Heat generation in magnetic hyperthermia originates from several heating loss 
mechanisms. The well-known mechanism is related to the eddy current heat loss occurring in 
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bulk materials. Eddy current can be induced by an altering magnetic field and is perpendicular to 
the plane of applied field. This current flowing through the material dissipates energy as the heat 
loss [22]. 
In the case of nano-sized materials, the eddy current heating loss is negligible. For 
particles of micro/nano dimensions, the dominant heating mechanism is hysteresis loss. In this 
case, heat generation occurs by dissipating thermal energy throughout the magnetic domains of 
ferromagnetic material. When the particle size is smaller than the superparamagnetic critical 
diameter, the hysteresis loss is presented in terms of the Néelian and Brownian relaxation (see 
Fig. 2a). The Néelian relaxation is attributed to the heat generated by rotation of discrete 
magnetic moments in the magnetic particles; whereas the Brownian relaxation is attributed to 
the heat generated by physical rotation of particles originating from alignment of magnetic 
moments with the applied magnetic field [22]. 
Hyperthermia therapy has been successfully applied along with chemo- or radio-therapy 
for treatment of primary cancerous tumors, as these tumorous cells are more susceptible to 
hyperthermic effects. Fig. 2b shows the vascular and cellular effects of hyperthermia on heated 
tumor tissues. Hyperthermia leads to induce different physiological responses from the heated 
defected tissues. In view point of vascular effects, these responses comprise increased blood 
flow, vasodilation, and enhanced permeability. These effects can result in altering of pH as well 
as microenvironment conditions of tumors. In view point of cellular effects of heperthermia 
therapy, several cellular processes such as biomolecular assemblies and cellular mechanisms 
responsible for onset of acidosis or apoptosis may be disrupted through protein denaturation, 
aggregation, and DNA cross-linking [23]. 
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Fig. 2. (a) Different heat generation mechanisms in magnetic nanoparticles subjected to the altering magnetic field. 
The short straight arrows show the direction of magnetic moment. The curved arrows show the movement or 
change of direction, and the dash lines show the domain interfaces in multi-domain magnetic particles. The Néelian 
relaxation is attributed to the heat generated by rotation of discrete magnetic moments in the magnetic particles; 
whereas the Brownian relaxation is attributed to the heat generated by physical rotation of particles originating 
from alignment of magnetic moments with the applied magnetic field. (reprinted with the permission from [22]) 
(b) Vascular and cellular effects of hyperthermia on heated tumor tissues. Vascular effects comprise increase of 
blood flow, vascular permeability, and vasodilation. Cellular effects comprise DNA repair inhibition, protein 
denaturation, and upregulation of heat shock proteins. (reprinted with the permission from [23]). 
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2.2. Ferromagnetic and ferrimagnetic materials 
Iron, nickel, and cobalt are the most pertinent examples of ferromagnetic materials. 
Some classes of amorphous metallic alloys and rare earth compounds are also known as 
ferromagnetic materials [24]. Ferrites are the most important ferrimagnetic materials having the 
spinel configuration with the common chemical formula AB2O4 [25]. The spinel structure consists 
of a cubic close-packed arrangement of oxygen anions, with A and B cations placed in two 
different crystallographic sites with tetrahedral and octahedral oxygen coordination, 
respectively. The spinel configuration includes 8 A-sites and 16 B-sites. As the A-sites are 
occupied by A cations and the B-sites are occupied by B cations, known as “normal spinel”. If the 
A-sites are fully occupied by B cations and the B-sites are randomly occupied by A and B cations, 
the structure is “inverse spinel” [26]. In most spinels, the cation distribution retains a middle 
degree of inversion where both sites hold a fraction of the A and B cations. In ferrites, the 
common formula may be presented as QFe2O4, in which Q is a bivalent cation and iron is the 
trivalent cation [27]. Complex oxide compounds with dissimilar crystal structures may similarly 
be ferrimagnetic, for example, the hexagonal ferrites and garnets [28]. Hexagonal ferrites have a 
crystal structure similar to the cubic inverse spinel, but with a hexagonal symmetry. The chemical 
formula of these materials could be shown by AB12O19, in which A is a bivalent cation such as Ba, 
Sr, Pb, and B is a trivalent cation such as Al, Cr, or Fe [29, 30]. The two most public examples of 
the hexagonal ferrites are BaFe12O19 and PbFe12O19. 
Magnetic nanoparticles produced by different methods such as micelles and co-
precipitation have appealed large research attention in current years [31, 32]. These structures 
showed to be suitable for providing manageable particle size and morphology, as well as for 
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attaining narrow particle size distribution. To assure homogeneous dispersion of magnetic 
nanoparticles in liquid suspensions, the synthesis conditions have been properly tailored. 
Additional surface functionalization has been used for this purpose, like coating with various 
materials including organic polymer (e.g. chitosan, polyethylene glycol), oxides (e.g. silica, 
alumina) or metals (e.g. gold, silver) [31-34]. 
Furthermore, nano-structured magnetic crystalline phases can be obtained by the glass-
ceramic method much easier, with a relatively lower production cost. In this method, it is 
possible to obtain a wide range of magnetic crystalline phases with different chemical 
compositions and fine-grained microstructures [33, 34]. Glass-ceramics are fabricated by 
controlled crystallization of starting glasses produced via melt-quenching or sol-gel processes. 
Crystallization usually occurs in a two-step heat treatment schedule containing nucleation and 
growth of crystalline phases. Depending on the chemical composition of the starting glass, 
desired crystalline phases with relevant specific features could be precipitated during the heat 
treatment process. On the other hand, by controlling the heat treatment parameters, such as 
heating rate, soaking temperature and time, it is possible to obtain the targeted microstructure 
with a uniform distribution of crystalline phases in the residual glass matrix. 
 
3. Glass-ceramics for cancer treatment via magnetic hyperthermia 
3.1. The origin of magnetic glass-ceramics for biomedical applications 
During the last few decades, numerous types of glasses and glass-ceramics have been 
developed for clinical applications due to their exceptional characteristics, such as 
biocompatibility, bioactivity, osteoconductivity, and osteo-productivity. When this class of 
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biomaterials implanted in the body, the precipitated apatite layer on their surface usually leads 
to the formation of chemical bonds between the implanted biomaterial and the living tissue [35]. 
The development of magnetic glass-ceramics with acceptable bioactivity has recently received 
much attention as thermo-seed materials in cancer treatment (especially in the case of deep-
seated bone tumors). In magnetic bioactive glass-ceramics, magnetic crystalline phases generate 
heat under an external altering magnetic field and the residual glass matrix is responsible for 
bioactivity. 
Generally, these deep-regional tumors are effectively destroyed when heated up to 45 
°C, without any significant damage to the neighboring normal tissues [36]. Magnetic glass-
ceramics implanted around cancerous bone tissues produce sufficient heat by the magnetic loss. 
The generated heat as a result of magnetic loss is influenced by several features such as 
magnetic properties of the material, amount of magnetic crystalline phases, strength and 
frequency of the applied altering magnetic field, the glass-ceramic microstructure, and etc. [10, 
11, 37]. As mentioned previously, glass-ceramics are conventionally prepared by heat treatment 
of a starting glass. Therefore, the type and size of the crystallized phases are extremely 
dependent on the heat treatment parameters. Since the synthesis method of magnetic glass-
ceramics is very effective in terms of magnetic properties, other synthesis routes like sol-gel have 
been also examined in recent years [37, 38]. It is known that sol-gel technique can intrinsically 
produce controllable size and distribution of the particles. 
In vitro bioactivity of magnetic bioactive glass-ceramics has been commonly evaluated by 
examining apatite formation ability in contact with simulated body fluids (SBF). It is confirmed 
that glass-ceramics are able to bond to living hard tissues through the formation of an apatite 
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layer after SBF immersion [39]. The magnetic properties of this class of biomaterials have been 
investigated using vibrating sample magnetometer (VSM) at room temperature. Generally, the 
magnetic hysteresis loops of glass-ceramics evaluated using two different high (≥10 kOe) and low 
(500 Oe) magnetic field intensities. The first magnetic field value is sufficient to measure 
saturation magnetization. Low-field measurements are suitable for clinical laboratory conditions 
[10]. Moreover, magnetic heat generation or calorimetric measurements of magnetic glass-
ceramics are typically performed using a magnetic induction furnace at a magnetic field of about 
500 Oe (∼400 kHz) [8, 11]. 
Overall, magnetic bioactive glass-ceramic can not only be used for the cancer 
hyperthermia but also as a bone substitute biomaterials for the regeneration of damaged hard 
tissues [10, 40]. Owing to the balanced bioactivity and magnetic characteristics, magnetic 
bioactive glass-ceramics having acceptable hyperthermic features have been widely investigated. 
Table I summarizes major studies on the use of magnetic glass-ceramics for cancer treatment. 
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Table I. A research summary on magnetic bioactive glass-ceramics for cancer treatment. 
Glass composition 
Preparation 
technique 
Magnetic Properties 
Bioactivity/Biocompatibility evaluation Main results Ref. 
Saturation 
magnetizati
on (emu/g) 
Coercive force 
(Oe) 
30CaO, 30SiO2,  
40Fe2O3 (wt %) 
melt quenching 
100 
(emu/cm3) 
382.0 - 388.2 
___ / Biocompatibility confirmed from 
the results of agar diffusion test with 
L929 cells. 
The heat-generating power of ferrimagnetic glass-
ceramics improved by prohibiting other crystalline 
phase formation and magnetite oxidization through 
the addition of each 1% of P2O5 and B2O3. 
[6] 
24.5Na2O, 24.5CaO, 6P2O5, 45SiO2 (wt 
%) 
melt quenching Up to ~ 22 2900 - 4400 
The samples demonstrated a bioactive 
behavior in SBF (two weeks 
immersion). / ___ 
The addition of BaFe12O19 (BF) improved both 
magnetic behavior and bioactivity of the final 
samples. 
[36] 
24.5Na2O, 24.5CaO, 6P2O5, 45SiO2 (wt 
%) 
melt quenching Up to ~ 17 Up to ~ 5200 
A hydroxy carbonated apatite layer 
found on the surface of all samples 
confirming their bioactivity, which 
increased with increasing of strontium 
ferrite content. / The samples showed 
no sign of toxicity in contact with 
human fetal osteoblastic hFOB cells 
The addition of SrFe12O19 (SrF) not only improved 
the magnetic properties of the 45S5 bioactive glass-
ceramics but also enhanced the bioactivity and 
biocompatibility of them, especially for the highest 
SrF content sample (40% SrF). 
[37] 
45CaO, 33SiO2, 16P2O5, 4.5MgO, 
0.5CaF2 (wt %) 
Sol-gel 4.63 - 9.72 90 - 300 
The addition of Mn-Zn ferrite to the 
samples decreased the bioactivity 
behavior. / ___ 
Mn-Zn ferrite content had a direct relationship with 
the saturation magnetization and coercive force  
[38] 
40(FeO, Fe2O3), 60CaO, xSiO2 (wt %) melt quenching 32 500 
Addition of Na2O or combination of 
B2O3 and P2O5 to the basic composition 
resulted in apatite formation in SBF. / 
___ 
Ferrimagnetic glass-ceramics in FeO-Fe2O3-CaO-
SiO2 system showed bioactivity, by the small 
addition of Na2O, B2O3 and/or P2O5 (3 %.wt). 
[39] 
41CaO, (52-x)SiO2, 3Na2O, 4P2O5, 
xFe2O3 (x = 0, 2, 4, 6, 8 and 10 mol %)  
melt quenching 0.17 - 7.95 91 - 523 ___ / ___ 
Magnetic properties of samples varied with the 
processing parameters. 
[41] 
13.5CaO, 24.7SiO2, 13.5Na2O, 3.3P2O5, 
14FeO, 31 Fe2O3  
(wt %) 
melt quenching 18.6 - 31.5 35 - 180 
The samples demonstrated a bioactive 
behavior in SBF (two weeks 
immersion). / ___ 
The magnetic features significantly changed by 
altering the melting temperature. 
[42] 
60Fe2O3, 14.3CaO, 10.37 ZnO, 
15.32SiO2, 3B2O3 (wt %) 
melt quenching 
23.13 - 
52.13 
7.21 - 95.93 ___ / ___ 
The presence of ZnO led to the higher degree of 
crystallinity and improved magnetic properties. 
[43] 
43CaO, 43SiO2, 14Zn0.4Fe2.6O4 (mol%) melt quenching 6.7 - 38.4 10.7 - 167.6 ___ / ___ 
The magnetic features varied with the soaking 
temperature and time period of applied heat 
treatment. 
[44] 
(65-x)SiO2, 20(CaO,P2O5), 15Na2O, melt quenching 0.41 - 19.6 44 - 204 Bioactivity increased with the increase Ferrimagnetic contribution observed for x≥9 mol% [45-
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x(ZnO,Fe2O3) 
(6≤ x ≤21 mol%) 
of zinc–iron oxide content. / ___ (zinc-iron oxide). 47] 
25CaO, (40-x)SiO2, 7P2O5, 3Na2O, 
xZnO, 25Fe2O3  
(x=4, 6, 8, 10 wt %) 
melt quenching 14.7 - 21.8 150 - 244 
The samples demonstrated a bioactive 
behavior in SBF (three weeks’ 
immersion). / ___ 
The magnetic and heat generating properties 
enhanced by increase of ZnO content and aligning 
magnetic field. 
[10, 
11, 
40] 
4.6MgO, 44.9CaO, 34.2SiO2, 16.3P2O5, 
0.5CaF2 (wt %) 
Sol-gel 7.2 175 
The addition of Mg ferrite decreased 
bioactivity, shown by hydroxy 
carbonated apatite layers (two weeks 
immersion). / The magnetic glass-
ceramic samples showed no sign of 
toxicity in contact with osteoblast-like 
ROS17/2.8 cells (cell attachment) 
Adding Mg ferrite led to the acquisition of magnetic 
property with a narrow hysteresis loop and a small 
coercive field. 
[48] 
(45-x)CaO, 34SiO2, 16P2O5, 4.5MgO, 
0.5CaF2, xFe2O3 (x = 5-20 wt %) 
melt quenching 0.21 - 8.89 149 - 575 
Bioactivity increased by further 
addition of iron content. / ___ 
Higher iron oxide content not only enhanced bone 
formation but also improved crystallization degree 
of magnetic phase. 
[49] 
25Li2O, 8MnO2, 20CaO, 2P2O5, 45SiO2 
(at %) 
melt quenching ˂ 1 Up to 63 ___ / ___ 
Among the glass-ceramics based on (Li, Mn) ferrite 
as the magnetic phase, only samples containing 8 
at % Fe2O3 showed ferromagnetic behavior at room 
temperature. 
[50] 
40Fe2O3, 15P2O5, 20SiO2, 5TiO2 (wt %) melt quenching ___ ___ 
The glass-ceramics containing 20% 
metal oxides (MgO, CaO, MnO, ZnO, 
CeO2, CuO) showed bioactivity in SBF 
(within 7 to 30 days). / ___ 
The fabricated glass-ceramics possessed bioactivity 
by addition of 20 % metal oxides, such as MgO, 
CaO, MnO, ZnO, CeO2, and CuO. The apatite 
formation depended upon the type of the metal 
oxide. 
[51] 
15.9Na2O, 15.9CaO, 29.3SiO2, 3.9P2O5, 
10.9FeO, 24.1Fe2O3 (wt %) 
concurrent 
sintering and 
crystallization 
15 144 ___ / ___ 
Glass-ceramics containing nanocrystals of 
magnetite, uniformly dispersed in the glass matrix 
and further crystallized during fast cooling of 
molten glass. The content of iron oxide in the glass 
composition showed a great influence on the 
magnetic behavior. 
[52] 
13.5Na2O, 13.5CaO, 24.7SiO2, 3.3P2O5, 
14FeO, 31Fe2O3 (wt %) 
concurrent 
sintering and 
crystallization 
26 - 33 82 - 220 
The bioactivity assessment, performed 
by immersing the samples in SBF up to 
one month evidences the formation of 
silica gel along with precipitates rich in 
Ca and P after 14-28 days of 
immersion. 
All iron ions contribute to the crystalline structure 
of magnetite, and uniformly distributed in the 
amorphous glass matrix. The magnetic hysteresis 
parameters strongly influenced by microstructure, 
which was in turn governed by melting 
temperature. The magnetic glass-ceramics showed 
slow bioactivity kinetics. The samples could be 
functionalized with antineoplastic drugs. 
[52-
55] 
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3.2. Experimental background of glass-ceramics in cancer treatment 
Magnetite (Fe3O4) is a representative ferrimagnetic material and the most recommended 
for biomedical applications. Preparation of magnetite-containing glass-ceramics has been widely 
reported by several researchers and not only for hyperthermia applications [56, 57]. 
Luderer et al. [58] published the first report on ferrite based glass-ceramics as 
thermoseeds for hyperthermia therapy in 1983. The glass-ceramics were fabricated in a ternary 
system of Al2O3-SiO2-P2O5 and contained lithium ferrite (LiFe5O8) and hematite (Fe2O3) as the 
crystalline phases; however, they were not bioactive and the heat generation of these materials 
was not sufficient to destroy the malignant carcinoma [58]. Therefore, ferrimagnetic 
thermoseeds having higher heat generating power were required. 
In 1991, Ebisawa et al. prepared another non-bioactive ferrimagnetic glass-ceramic in 
which Fe3O4 crystals uniformly dispersed in the residual glass matrix with CaO.SiO2 chemical 
composition [59]. They showed that CaO-SiO2 system glasses containing iron oxide could form 
ferrimagnetic glass-ceramics upon heat treatment at elevated temperatures. By heat treatment 
of the starting glass at 950 °C, a glass-ceramic containing 36 wt % of magnetite in the glass 
matrix of CaO.SiO2 obtained. The magnetic properties of this glass-ceramic originated from 
transformation of hematite to magnetite during heat treatment [59]. In the latter study [60], 
Ebisawa et al. showed that ferrimagnetic Fe2O3-containing CaO-SiO2 glass-ceramics could obtain 
bioactivity by addition of small amounts of Na2O, B2O3 and/or P2O5 to the composition of the 
starting glass [60]. In this regard, they studied in vitro bioactivity of ferrimagnetic glass-ceramics 
with the compositions of 60CaO.SiO2, 40(FeO, Fe2O3) contained 3 weight ratios of Na2O, B2O3 
and/or P2O5. They found that concurrent presence of P2O5 with Na2O or B2O3 induced bioactivity 
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in the studied glass-ceramics [39]. It could be inferred that glass-ceramics of the FeO-Fe2O3-CaO-
SiO2 system could show bioactivity as well as ferrimagnetism by the small addition of certain 
oxides [39]. Since then, various magnetic bioactive glass-ceramics based on the CaO-SiO2 glasses 
containing iron oxide have been reported. 
 
3.3. Current research on the development of glass-ceramics for cancer treatment 
Seung-Han Oh et al. [13], improved the heat-generating power of ferrimagnetic CaO-
Fe2O3-SiO2 glass-ceramics by prohibiting precipitation of undesired crystalline phases as well as 
magnetite oxidization to hematite during heat treatment [13]. For this purpose, crystallization 
temperature was fixed above 880 °C to avoid undesirable precipitation of crystalline phases such 
as β-wollastonite (CaSiO3). Furthermore, the addition of each P2O5 and B2O3 (1 %) to the glass 
composition led to the significant decrease of crystallization temperature from 1000 to 940 °C, 
via decreasing the glass viscosity. Since magnetite crystals can be easily oxidized above 900 °C in 
air, the oxide additives can be helpful to suppress the oxidation probability [13]. Moreover, a 
preclinical evaluation of the as-quenched and heat treated glasses using L929 cells revealed the 
biocompatibility of these materials [13]. 
In the study carried out in 2005, Leventouri et al. [41] prepared ferrimagnetic bioactive 
glass-ceramics in the system of CaO-SiO2-P2O5-Na2O-Fe2O3 through a standard melt processing 
technique. They have shown that the magnetic properties could vary with the processing 
parameters which govern the structure and microstructure of these materials [41]. In another 
research conducted by Singh et al. [61], magnetic properties of glass-ceramics resulting from 
glasses with the composition of 41CaO, (52-x)SiO2, 4P2O5, 3Na2O, xFe2O3 evaluated as a function 
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of Fe2O3 content [74]. The structural study revealed the presence of magnetite nanocrystals in 
the heat-treated samples containing higher than 2 mol % of Fe2O3, besides biocompatible 
crystalline hydroxyapatite (Ca10(PO4)6(OH)2) and wollastonite (CaSiO3) [61]. Evaluation of 
magnetic properties of these glass-ceramics by adding different concentrations of iron oxide and 
its relationship has been understood based on the variation in saturation magnetization, 
coercivity, and hysteresis loop. Generally, the samples with higher than 2 mol % of iron oxide 
demonstrated a magnetic characteristic nearly similar to the soft magnetic materials having 
narrow hysteresis loop and low coercive force. According to the obtained results, the coercivity 
of the samples decreased with the increase of Fe2O3 content. However, saturation magnetization 
and the area under the hysteresis loop showed an adverse trend. Since the area under the 
hysteresis loop is proportional to the magnetic loss and produced heat, samples with higher 
Fe2O3 content are capable to generate more heat. 
Ferrimagnetic bioactive glass-ceramics belonging to the CaO-SiO2-P2O5-Na2O-FeO-Fe2O3 
system have been developed by Bretcanu et al. [42]. These glass-ceramics have been extensively 
characterized in terms of electromagnetic properties and heat generation ability, showing a very 
narrow magnetic hysteresis loop, typical of ferrimagnetic materials [42, 53, 62, 63]. In this 
research, two series of ferrimagnetic glass-ceramics were prepared through different melting 
procedures of both commercial and co-precipitation-derived reagents [42]. Then, the effects of 
melting procedure and temperature on the magnetic properties and heat generation ability of 
both series were compared. In both procedures, glass-ceramics were directly obtained by 
cooling of the molten glasses on metallic bars, without using any crystallization heat treatment. 
The obtained results confirmed the relevancy between magnetic properties and 
  
18 
 
microstructure/melting temperature of the ferrimagnetic glass-ceramics. For all glass-ceramics 
prepared through the first procedure, the crystalline phases were mainly magnetite and 
hematite. The crystallinity of magnetite increased with an increase in the melting temperature. 
The glass-ceramics obtained by the second procedure contained a higher quantity of magnetite 
compare to that of glass-ceramics obtained from commercial reagents [42]. The maximum 
amount of magnetite crystallized in the second glass-ceramic series was about 45 wt % [7]. 
Room-temperature magnetic measurements, performed by means of a vibrating sample 
magnetometer (VSM), showed higher values of saturation magnetization for glass-ceramics 
obtained through melting of co-precipitation-derived reagents. Similar results were also 
achieved for coercivity values. Furthermore, calorimetric tests showed that the samples 
synthesized through commercial reagents demonstrated higher values of specific power losses. 
The specific power loss represents the thermal energy which generates heat [42]. It has been 
reported that this class of glass-ceramics could also show bioactive features [7]. 
In the research by Abdel-Hameed et al. [43], two series of ferrimagnetic glass-ceramics in 
the CaO-SiO2-Fe2O3 system with a high quantity of Fe2O3 (60 wt %) and small amounts of B2O3 
and ZnO were prepared. The chemical composition of one series (called FW) was similar to the 
composition of wollastonite, and the other series (called FH) was similar to the composition of 
hardystonite (Ca2ZnSi2O7). This work aimed to find a correlation between magnetic properties 
and chemical composition, amount of crystallized magnetite and microstructure of the examined 
glass-ceramics [43]. Microstructural investigations showed the precipitation of magnetite 
nanocrystals in the glass matrix of the as-prepared samples, without any heat treatment. The 
amount of crystallized magnetite in the FH series was higher than that of the FW series [43]. 
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When subjected to the subsequent heat treatment at 800 °C for 1h, magnetite, and hematite 
crystallized as the major and minor crystalline phases, respectively in FW glass-ceramic series. FH 
glass-ceramic series had similar crystalline phases in addition to trace amount of wollastonite. 
According to the microstructural measurements, the crystallite size of magnetite was governed 
by heat treatment parameters for both glass-ceramic series [43]. The analysis of magnetic 
hysteresis cycles confirmed that all samples exhibited soft magnetic behavior, with small 
coercivity. The studied FW and FH samples had a saturation magnetization of 35.25 and 52.13 
emu/g, respectively. Both samples were able to increase the temperature of distilled water to 
more than 40 °C under a magnetic field, being effective for destruction of tumors by magnetic 
heat generation of 10 W.g-1 [43]. 
In a study by Kawashita et al. [44], glass-ceramic powders containing zinc-iron ferrite 
(ZnxFe3-xO4) in a CaO-SiO2 matrix were prepared by heat treatment of initial glasses with the 
chemical composition of 43CaO, 43SiO2, 14Zn0.4Fe2.6O4 (mol %) in a controlled atmosphere. The 
effect of various soaking temperatures and time periods of heat treatment on the properties of 
the glass-ceramics were examined [44]. It was found that ZnxFe3-xO4 phase precipitated above 
700 °C, and its content and crystallite size, as well as saturation magnetization, increased with 
the increase of heat treatment temperature up to 1150 °C. During the heat treatment, the 
coercive force of these glass-ceramics firstly increased up to 1000 °C and then decreased with 
further increase of heat treatment temperature. By the increase of time period of heat 
treatment from 1 to 5h at the soaking temperature of 1150 °C, the content of the ZnxFe3-xO4 
remained constant, whereas the crystallite size and coercive force of the heat-treated powders 
increased. However, the saturation magnetization was decreased. Additionally, the powders 
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heat treated at 1150 °C for 5h showed a maximum amount of heat generation (12.4 W.g-1). This 
glass-ceramic containing ZnxFe3-xO4 could act as an effective thermoseed material in 
hyperthermia treatment of cancer due to the significant heat generating ability [44]. 
Singh and Srinivasan [45-47], have prepared a series of ferrimagnetic bioactive glass-
ceramics via heat treatment of bulk pieces of glasses with the chemical composition of (65-
x)SiO2, 20(CaO, P2O5), 15Na2O and x(ZnO, Fe2O3) (6≤ x ≤21 mol %) for applications in 
hyperthermia. From structural studies, it was found that calcium sodium phosphate (NaCaPO4) 
and zinc ferrite (ZnFe2O4) were the main crystalline phases in the synthesized samples [46, 47]. 
Magnetic properties of the glass-ceramics originated from the amount and size of zinc ferrite 
nanocrystals in the microstructure[47]. Variation of magnetic properties from a partially 
paramagnetic to a fully ferrimagnetic and its relationship with the zinc-iron oxide content was 
also observed in the studied glass-ceramics [46, 47]. Magnetization curves of the glass-ceramics 
containing different zinc ferrite contents (shown in Fig. 3) revealed that for zinc-iron oxide up to 
9 mol %, the samples exhibited both ferrimagnetic and paramagnetic behaviors; whereas, the 
samples having more than 9 mol % showed only ferrimagnetic features. As can be realized from 
Fig. 3, the magnetization curves for the samples with x= 6 and 9 mol % did not saturate even by 
applying a magnetic field of 20 kOe. However, the magnetization curves of the samples with x= 
12, 15, 18 and 21 mol % were saturated [46]. The maximum magnetic hysteresis loss was 
obtained for the synthesized glass-ceramics having a higher amount of zinc ferrite in the initial 
glass composition [47]. Moreover, biomineralization studies indicated that the samples were 
able to form apatite layers on the surface of the glass-ceramics as a function of zinc-iron oxide 
content [45, 46]. 
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Fig. 3. Magnetic hysteresis loops of (65-x) SiO2, 20(CaO, P2O5), 15Na2O, x (ZnO, Fe2O3) glass-ceramics as a function of 
zinc-iron oxide concentration (under a magnetic field strength of ±20 kOe). (a) An expanded view of hysteresis 
loops. (b) The initial magnetization curves of the sample with 6 and 9 mole% zinc–iron oxide. As can be seen, the 
required magnetic field to reach the saturation value increases with the further addition of zinc–iron oxide content 
in the glass-ceramic samples. However, there is no tendency for saturation magnetization for the samples with 6 
and 9 mole % zinc–iron oxide concentrations even at ±20 kOe (reprinted with permission from [84]).  
 
 
With the aim of developing a ferrimagnetic bioactive glass-ceramic that could bond to 
the living tissues in a physiological environment, Shah et al. [10] reported a series of samples on 
the basis of zinc-ferrite (ZnFe2O4) for cancer treatment. The relevant glass-ceramics were 
prepared by quenching the molten glasses with the chemical composition of 25CaO, (40-x)SiO2, 
7P2O5, 3Na2O, xZnO, 25Fe2O3 (x = 4, 6, 8, 10) that consequently heat-treated at 1100 °C [10]. 
Microstructural analyses revealed the presence of three prominent crystalline phases including 
zinc ferrite, wollastonite and hydroxyapatite [10]. In this research, ZnFe2O4 revealed a 
ferrimagnetism characteristic due to the random contribution of Zn2+ and Fe3+ cations into the 
tetrahedral A and octahedral B sites, resulting in the formation of an inverse spinel crystalline 
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structure. This structure could be attributed to the rapid cooling of the material from 1100 °C 
which preserved the high-temperature state of the randomly distributed ions [10]. Magnetic 
evaluation of these ferrimagnetic glass-ceramics by VSM data showed that saturation 
magnetization and coercive force increased with the addition of ZnO [10]. Since the nano-sized 
ZnFe2O4 crystals have shown a pseudo-single domain structure, the coercivity increased with the 
growth of crystals. Fig. 4 shows the dependency of coercivity on the crystallite size of zinc-ferrite 
as a function of ZnO content [10]. Calorimetric measurements, carried out using a magnetic 
induction furnace at 500 Oe magnetic field and frequency of 400 KHz, showed that the 
maximum specific power loss and temperature increase were 26 W.g-1 and 37 °C, respectively, 
for the sample contained 10 % ZnO [10]. 
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Fig. 4. Variations of ZnFe2O4 crystallite size versus ZnO content in 25CaO, (40-x) SiO2, 7P2O5, 3Na2O, xZnO, 25Fe2O3 
glass-ceramics and coercivity force at 10 KOe and 500 Oe. As can be seen, the crystallite size increases with the 
further addition of ZnO. In addition, the coercivity values increase with crystallite growth of ZnFe2O4. Although 
coercivity commonly decreases by the increase of crystallite size in the multi-domain structures (owing to the facility 
in rotation of domain walls), when the magnetite particle size lies in the range of 10-50 nm, a single domain 
structure is formed which requires an increased coercivity. Since the crystallite size of ZnFe2O4 is about 30-58 nm, it 
can be deduced that a pseudo-single domain structure of ZnFe2O4 crystallites is responsible for the increase of 
coercivity. (reprinted with the permission from [10]). 
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In other research [11, 40], Shah et al. have tried to enhance the magnetic and heat 
generating properties of the ferrimagnetic zinc-ferrite based bioactive glass-ceramics by control 
of the magnetic field. In order to induce magnetic anisotropy, after preparation of ferrimagnetic 
bioactive glass-ceramics in the CaO-SiO2-P2O5-Na2O-ZnO-Fe2O3 system, the samples were heated 
up to 600 °C and cooled under a magnetic field. To better understand the actual performance of 
zinc-ferrite based glass-ceramics, the magnetically aligned samples compared with non-aligned 
ones [11, 40]. The VSM data taken at 10 KOe and 500 Oe (see Fig. 5) showed that the coercive 
force, remnant magnetization and hysteresis area increased for the aligned samples. In fact, the 
magnetic field applied during cooling could possibly force the magnetic domains to be aligned in 
the direction of the applied magnetic field, facilitating an easy axis of magnetization in the same 
direction. After cooling, the domains stuck aligned with the magnetic field, and stronger 
magnetic fields required to magnetize the sample in a different direction [11, 40]. It is implied 
from Fig. 5 that the variation of magnetic parameters became prominent for x= 8−12 due to the 
higher amount of ferrimagnetic zinc-ferrite crystalline phase [11, 40]. The calorimetric studies 
carried out by a magnetic induction furnace at 500 Oe and frequency of 60 kHz for the aligned 
sample with a maximum amount of zinc-ferrite showed that the maximum specific power loss 
and temperature increase were 4.4 W.g-1 and 6.3 °C, respectively [11]. Changing the frequency 
to 400 kHz led to a specific power loss of 31.5 W.g-1 and a temperature increase of 45 °C after 2 
min (see Fig. 6) [40]. These parameters indicated that the magnetic properties of the aligned 
samples greatly improved using a magnetic induction furnace. The variation of specific power 
loss was prominent for x = 8 and x = 10 related to the higher hysteresis areas [40]. Thus, the 
calorimetric properties and heating generation ability of zinc-ferrite based ferrimagnetic 
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bioactive glass-ceramics increased by cooling in an aligning magnetic field. According to the 
aforementioned discussion, it can be deduced that this material may produce temperatures 
required to destroy cancer cells when implanted in the tumorous tissue [11, 40]. The bioactivity 
tests confirmed the growth of precipitated apatite crystals, suggesting that the prepared glass-
ceramics were bioactive for further experiments [11, 40]. 
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Fig. 5. Variation of the magnetic parameters versus composition for magnetically aligned and non-aligned 25CaO, 
(40-x)SiO2, 7P2O5, 3Na2O, xZnO, 25Fe2O3 glass-ceramics, (a) Coercive force, (b) Remnant magnetization, and (c) 
hysteresis area. As can be seen, the variation of magnetic parameters became prominent for x= 8−12 due to the 
higher amount of ferrimagnetic zinc-ferrite crystalline phase. (reprinted with the permission from [11]). 
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Fig. 6. a) Variation of calorimetric parameters including; a) specific power loss, and b) temperature increase versus 
composition for magnetically aligned and non-aligned 25CaO, (40-x)SiO2, 7P2O5, 3Na2O, xZnO, 25Fe2O3 glass-
ceramics. It is evident that the aligned samples present higher amounts of calorimetric parameters compared to the 
non-aligned samples, especially for x = 8 and 10 (reprinted with the permission from [40]). 
 
 
Leenakul et al. prepared ferrimagnetic bioactive glass-ceramics by heat treatment of 
powder mixtures composed of different amounts of solid-state synthesized barium ferrite and 
45S5 bioglass powder [36]. Sodium-calcium silicate (Na2Ca2Si3O9) and barium ferrite (BaFe12O19) 
were identified as the major crystalline phases in all heat treated samples [36]. Magnetic 
hysteresis loops of the prepared samples were examined in order to highlight their capability for 
cancer treatment via magnetic hyperthermia. It was found that the saturation magnetization 
increases with the rise in the content of magnetic BaFe12O19. Furthermore, the coercivity of the 
samples decreased with the increase of BaFe12O19 content, owing to the multi-domain structure 
of BaFe12O19. On the other hand, the hysteresis loop area increased with the rise of BaFe12O19 
from 5 up to 40 wt %, under a magnetic field of ±10 kOe [36]. In vitro bioactivity measurements 
(14 days of the immersion in SBF) confirmed that all of the glass-ceramics possessed appropriate 
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bioactivity with the formation of a bone-like apatite phase. In a similar trend, bioactivity also 
increased with the increase of BaFe12O19 content [36]. Therefore, it can be deduced that the 
addition of BaFe12O19 into the 45S5 glass composition can improve both the magnetic properties 
and bioactivity of the material [36].  
It has been reported that strontium-doped silicate glass discs could enhance bone cell 
activity and promote osteoblast proliferation and alkaline phosphatase activity in a direct contact 
with human osteosarcoma cell line, Saos-2 cells [64]. In a study, Leenakul et al. developed 
magnetic bioactive glass-ceramics obtained from heat treatment of powder mixtures of 45S5 
bioglass® and different amount of strontium ferrite (SrFe12O19) [65]. All final glass-ceramic 
samples contained calcium silicate (Na4Ca4Si6O18), strontium ferrite (SrFe12O19) and iron oxide 
(Fe2O3) [65]. These SrF-SiO2-CaO-Na2O-P2O5 ferrimagnetic glass-ceramics showed wide hysteresis 
loops and high coercive fields indicating the basic characteristics of a hard magnetic material. 
The magnetic characteristics were highly influenced by the SrFe12O19 content in such a way that 
the saturation magnetization, remanence, and coercivity increased with the increase of 
SrFe12O19 [65]. In vitro bioactivity measurements illustrated the formation of hydroxyl carbonate 
apatite layer on the surface of all glass-ceramics confirming their bioactivity. The bioactivity also 
increased with the rise of the SrFe12O19 content [65]. Furthermore, the MTT assay cytotoxicity 
test using hFOB cells indicated that the studied glass-ceramic samples were non-toxic for the 
SrFe12O19 content of 5-40 wt % [65]. The addition of SrFe12O19 not only improved the magnetic 
properties of the 45S5-based glass-ceramics but also enhanced their bioactivity and 
biocompatibility, especially in the case of 40 wt % SrFe12O19 containing sample [65]. 
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In a similar research, Abbasi et al. [37] added strontium ferrite (SrFe12O19) to 45S5 
bioglass®. First, they synthesized the 45S5 glass powder by a solid-state reaction between soda-
lime-silica waste glass and reagent chemicals of calcium carbonate, sodium carbonate, and 
phosphorous oxide. Then, 5-20 wt % of SrFe12O19 powder (obtained via sol-gel technique) was 
added to the bioactive glass powder. Finally, the ferrimagnetic bioactive glass-ceramic samples 
were achieved by conventional sintering method and their structural and magnetic features 
along with bioactivity were examined [37]. According to the phase analysis results, three main 
crystalline phases of sodium calcium silicate (Na2Ca2Si3O9), sodium calcium phosphate 
(NaCaPO4), and strontium ferrite (SrFe12O19) precipitated in all prepared glass-ceramics. By 
increasing the starting strontium ferrite in the composition, the crystallite size of SrFe12O19 and 
magnetic features of the glass-ceramic samples including saturation magnetization, remanence 
magnetization, and coercive force values increased [37]. Moreover, the energy loss meaning the 
heat generated by the ferrimagnetic material increased and reached 75.85×103 erg.g-1 for the 
sample containing 20 % wt SrFe12O19, which is appropriate for hyperthermia therapy [37]. In this 
study, the Hanks solution in vitro test was used to evaluate the bioactivity of the glass-ceramic 
samples. It was shown that the starting time for the formation of hydroxycarbonate apatite layer 
on the un-modified glass-ceramics was one week, while at least two weeks were required for 
strontium ferrite containing samples. The authors concluded that the addition of strontium 
ferrite to the 45S5-based glass-ceramics could possibly decrease the bioactivity due to the fact 
that the amount of non-bioactive phase (magnetic phase) increased by the addition of strontium 
ferrite [37]. 
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In the paper published by Da Li et al. [48], a multi-component system of CaO-SiO2-P2O5-
MgO-CaF2-Fe2O3 bioactive glass-ceramics has been synthesized to which Mg ferrite added as the 
magnetic phase. The XRD studies showed the presence of wollastonite (CaSiO3), akermanite 
(Ca2MgSi2O7), fluorapatite (Ca5(PO4)3F) and magnesium ferrite (Fe2MgO4) in the final magnetic 
bioactive glass-ceramics. According to the magnetic characterization, these materials exhibited 
characteristics of soft magnets. From the in vitro bioactivity assessment, although the addition of 
Mg ferrite could possibly decrease the bioactivity of the initial glass-ceramic, a considerable 
amount of hydroxy carbonated apatite was still detectable on the surface of the samples in SBF 
after two weeks. Furthermore, the cellular and molecular experiments with osteoblast-like cells 
demonstrated that the magnetic glass-ceramic were biocompatible enough for biomedical 
applications [48].  
Singh and Srinivasan [87] synthesized and characterized a series of (45-x)CaO, 34SiO2, 
16P2O5, 4.5MgO, 0.5CaF2, xFe2O3 (where x = 0-20 wt %) ferrimagnetic bioactive glass-ceramics. 
From the structural analyses, hydroxyapatite, magnetite, and wollastonite were detectable as 
the main crystalline phases for all the samples having iron oxide in the composition. In addition, 
akermanite (Ca2MgSi2O7) was observed in the samples with higher iron oxide contents. The 
presence of akermanite in these glass-ceramics increased their hardness and load-bearing 
capability. The glass-ceramic samples were also evaluated under high and low magnetic fields. 
On the basis of magnetic characterization, the glass-ceramics with higher iron oxide 
concentration were capable to generate more heat at the same magnetic field. The results also 
showed that bioactivity increased as a function of iron content increment [49].  
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Da Li et al. [60] added Mn-Zn ferrite to the apatite-wollastonite glass-ceramics as the 
magnetic phase and synthesized an innovative class of magnetic bioactive glass-ceramics. They 
monitored the effects of various amounts of the magnetic additive on the phase evolution, 
magnetic properties, and bioactivity of the glass-ceramics [38]. In the modified glass-ceramics, a 
new phase of Zn0.75Mn0.75Fe1.5O4 was crystallized in addition to the apatite, fluorapatite, and 
wollastonite crystalline phases. Moreover, under an external magnetic field, the saturation 
magnetization and coercive force were respectively increased and decreased by the rise of Mn-
Zn ferrite concentration from 5 to 20 wt %. The bioactivity assessment indicated that the 
addition of Mn-Zn ferrite could considerably decrease the bioactivity of the glass-ceramics. An 
apatite layer precipitated on the surface of ferrite free apatite-wollastonite glass-ceramics after 
one week, while apatite precipitation on the surface of the modified glass-ceramics occurred 
after almost one month [38]. 
In the research reported by Hsi et al. [88], different series of glasses consisting of 25Li2O, 
8MnO2, 20CaO, 2P2O5, 45SiO2 (at %) have been developed having different amounts (0, 4, and 8 
at %) of Fe2O3. This research studied the crystallization behavior and magnetic characteristics of 
the prepared glass-ceramics [50]. The samples indicated surface crystallization behavior during 
heat-treatment. After 4h heat treatment at 850 °C, lithium manganite (LiMn2O4) along with 
silicate-based crystalline phases including β-wollastonite (β-CaSiO3), lithium silicate (Li2SiO3), 
Ca(Ca, Mn)Si2O6 and lithium calcium silicate (Li2Ca4Si4O13) precipitated in the Fe2O3 free glass-
ceramics. In the Fe2O3 containing samples, the presence of Fe2O3 in the composition led to the 
precipitation of (Li, Mn) ferrite phase. Li2FeMn3O8 crystalline phase was also identified in the 
sample contained 8 at % of Fe2O3 [50]. Microscopic observations showed the homogeneous 
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dispersion of (Li, Mn) ferrite crystals in the Si-rich matrix. On the basis of microstructural 
evaluations, the crystal size of (Li, Mn) ferrite could be controlled by the content of Fe2O3 in the 
glass-ceramic. The average crystal size of (Li, Mn) ferrite in the glass-ceramic contained 4 at % 
Fe2O3 was found to be 40 nm. As the crystal size of (Li, Mn) ferrite in the glass matrix became 
smaller than 40 nm, the magnetic characteristics exhibited a combination of both super-
paramagnetism and ferromagnetism. However, by further increase of crystal size, the magnetic 
behavior changed to ferro-magnetism [50]. 
In the research reported by  Abdel-Hameed et al [51], the in vitro bioactivity of magnetic 
glass-ceramics belonging to a multicomponent system of Fe2O3-TiO2-P2O5-SiO2 with the addition 
of various types of metal oxides (MgO, CaO, MnO, ZnO, CeO2, CuO) has been evaluated. The 
bioactivity assessment indicated the bioactivity of all the samples after immersion in SBF up to 
one month. Apatite formation was dependent on the type of the metal oxide. CaO, MgO, ZnO, 
and CeO2 added samples formed an apatite layer within one week, while MnO and CuO added 
samples needed 2-4 weeks. As a result, the addition of CaO or ZnO to the glass-ceramics 
exhibited the most promising results among the in vitro tested samples [51]. 
 
3.4. Magnetic bioactive glass-ceramics in polymer-matrix composites 
An interesting way to treat bone tumors by hyperthermia is based on the utilization of 
composite materials, made of a polymeric matrix embedding magnetic fillers. The polymeric 
matrix is generally a commercial bone-cement, such as polymethyl methacrylate (PMMA) and 
the magnetic fillers (magnetic ceramics or glass-ceramics), as well as magnetite micro- and 
nanoparticles [66-70]. Kawashita et al. [66] reported the synthesis of a PMMA-based bone 
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cement embedding Fe3O4 micro-particles. The curing parameters, compressive strength, and the 
heat generating ability have been reported and attributed to the amount of magnetite in the 
composites. In order to realize a multifunctional material, other authors reported the use of two 
different fillers added to the same polymeric bone cement including magnetite particles and 
micro-particles of a bioactive glass-ceramic or silica [67, 68]. The results obtained by the in vivo 
studies in a rabbit animal model evidenced the utility of a controlled hyperthermic treatment for 
bone tumors regression. Apart from the positive effects of magnetic hyperthermia on cancer 
treatment, there are few reports on the ability of magnetic bioactive glass-ceramics to 
accelerate bone formation. In this regard, Li et al. [71] have recently proposed a novel chitosan-
based tissue engineering scaffold with apatite-wollastonite-magnetic glass-ceramic particles for 
the enhancement of osteogenic capability in bone defects. To examine the developed scaffold in 
vivo, a series of rabbit models implanted with free scaffolds and rabbit bone marrow stromal 
cells (BMSCs) loaded scaffolds. The results indicated that the proposed scaffolds could 
potentially promote the osteogenic capability of the newly formed bone in vivo (see Fig. 7).  
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Fig. 7. (a) The prepared magnetic apatite/wollastonite glass-ceramic containing chitosan-based scaffolds implanted 
in rabbit (in a 1.5 cm bone defect). The X-ray slice of 12 weeks implanted scaffolds indicates that high-density 
calcified shadow is detectable in the experimental side, but not detected in the control side (indicated by 
the arrow), (b) Bone tissue in control side appears as green fluorescence. (c) Histological section of the implanted 
scaffolds shows that mature bone tissue can be detected between muscular tissues, indicating that the proposed 
magnetic bioactive scaffolds could potentially promote the osteogenic capability. (d) Histological section of control 
side indicates immature bone and cartilage tissue between muscular tissues. (reprinted with the permission from 
[71]). 
 
 
Composite bone cements with the ability to fill bone cavities and induce local 
hyperthermia have been significantly developed by dispersion of magnetite nanoparticles in a 
PMMA-based bone cement [69]. The compressive strength of the composites was not affected 
by the addition of nanoparticles in the polymeric matrix. It was found that the heat generation 
capacity was strongly dependent both on the magnetic nanoparticles diameter and the external 
magnetic field parameters. The mentioned composites did not include any bioactive phase, so it 
could not promote bone tissue integration. In this regard, Bruno et al. [54] developed a bone 
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cement composed of a PMMA matrix loaded with the ferrimagnetic and bioactive glass-ceramic 
particles, previously synthesized and characterized by Bretcanu et al. [7]. The ferrimagnetic and 
bioactive glass-ceramic micro-particles have been incorporated in the PMMA polymeric matrix in 
different amounts (10-20 wt %), maintaining the same monomer/solid phase (PMMA/glass-
ceramic) ratio of the commercial formulation. Morphological and compositional 
characterizations confirmed a uniform dispersion of glass-ceramic particles in the polymeric 
matrix as well as their good exposition at the cement surface, assuring the needed bioactive 
behavior of the composite material. Any signs of particle agglomeration, which can cause a 
detriment to the mechanical properties, were not noticed. In fact, by tailoring the size and the 
content of the glass-ceramic particles in the cement appropriate compressive and bending 
strengths were obtained, in accordance with the ISO 5833 standard required values. All the 
cement compositions have been also demonstrated to be able to generate heat under an 
external altering magnetic field. Furthermore, it has been confirmed that the power loss 
amplified as a function of the ferrimagnetic glass-ceramic phase and the magnetic field intensity. 
The in vitro properties of the mentioned composite cements have been evaluated by 
Vernè et al. [72]. Leaching behavior and bioactivity of the composite cements have been 
evaluated in SBF for different time intervals. Since there was no evidence for iron release from 
the samples, no sign of toxicity could be expected in the body fluids. Morphological and 
compositional analyses performed after soaking in SBF showed the precipitation of 
hydroxyapatite after one month; thus, evidencing a suitable exposition of the magnetic glass-
ceramic at the cement surface. Cytocompatibility test has been also carried out using human 
osteosarcoma cells MG63. Cell viability, adhesion and spreading on the composite cements were 
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very high. Moreover, the cells demonstrated the ability to develop bridge-like structures as well 
as tridimensional cell multilayers after a few days of culture. A synergistic effect between cells 
activity and bioactivity of the ferrimagnetic glass-ceramic phase was also evidenced. Therefore, 
the glass-ceramics proposed by Bretcanu et al. [7] could be successfully used, as bioactive and 
magnetic fillers embedded in a polymeric matrix, for the development of a single implantable 
material with different therapeutic functions to treat bone tumors and associated complications. 
 
3.5. Surface functionalization of magnetic bioactive glass-ceramics 
The surface grafting of implantable devices with biomolecules or drugs represents a new 
approach for targeted local administration of therapeutic agents [73, 74]. Silica-based bioactive 
glass-ceramics can be surface activated in different ways in order to develop reactive sites, which 
in turn can bond different molecules, including antineoplastic agents [75]. Some researchers 
reported the surface functionalization of both inert and bioactive silica-based glasses [76-79]. In 
particular, the ferrimagnetic and bioactive glass-ceramics developed by Bretcanu et al. [7] have 
been surface functionalized with antineoplastic agents [55, 80]. Specifically, cisplatin and 
doxorubicin have been grafted after a surface activation to expose hydroxyls, functional groups. 
Both antineoplastic agents have been able to bind with exposed groups and their release from 
the glass support have been studied in different aqueous solution. The possibility of tailoring the 
release profile as a function of the desired therapeutic action was also investigated. Moreover, 
the functionalized glass-ceramic maintained its bioactivity and so it can be used as a magnetic 
and bioactive drug carrier. The functionalization of a ferrimagnetic bioactive glass-ceramic with 
gallic acid has been also investigated considering its potential applications in hyperthermic 
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treatment as well as the anticancer action of gallic acid [81]. In the relevant works, glass-
ceramics both in bulk and powder forms have been surface grafted with gallic acid. The grafting 
procedure has been optimized to preserve gallic acid activity and the stability of the 
functionalized surface. The functionalization effectiveness has been examined with the presence 
and reactivity of gallic acid. The results of this research suggested that the magnetic bioactive 
glass-ceramics functionalized with natural polyphenols could act as promising biomaterials for 
bone tissue engineering and regenerative medicine in critical cancerous conditions. 
Lin et al. [82] functionalized mesoporous bioactive glasses with folic acid in order to 
obtain a localized site-specific anticancer delivery system. They compared the release of a 
hydrophobic anticancer drug camptothecin from both unmodified and modified glass samples. 
The results revealed a sustained-release pattern of camptothecin, with a greater cytotoxicity 
behavior compared with the unloaded samples. The authors explained that the increased 
cytotoxicity for the loaded samples was due to the enhanced cellular uptake of the anticancer 
drug delivery vehicles mediated by the folic acid receptor. They concluded that the use of 
functionalized mesoporous bioactive glasses could be taken into the consideration as an 
appropriate strategy for the delivery of anticancer drugs. Fig. 8 resumes different potential 
applications of magnetic glass-ceramics developed by Verné et al. [80] ranging from composites 
to highly specialized functionalized systems. 
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Fig. 8. Magnetic bioactive glass-ceramics of the SiO2-Na2O-CaO-P2O5-FeO-Fe2O3 multicomponent system and its 
potential applications as magnetic bioactive monoliths, bioactive magnetic composites, gallic acid (GA) 
functionalized glass-ceramics and magnetic bioactive drug carriers. (partially reprinted with the permission from 
[80]) 
 
 
4. Mesoporous glasses for anti-cancer drug delivery 
Nanoparticles are one of the most favorable alternatives for enhancing the delivery of 
bioactive materials with the ability to enhance their therapeutic effectiveness [83, 84]. Though 
nanoparticles fall in the range of 1-100 nm [85], they also contain sub-micron particles smaller 
than 1000 nm [86, 87]. Glass nanoparticles could be obtained from both melt quenching and sol-
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gel techniques [88-92]. Melt-derived nanoparticles can be obtained from flame synthesis. In this 
method, starting materials rapidly melt and change to glass particles through the main flame 
stream [93]. The sol-gel method provides the possibility to obtain various nanoparticles at room 
temperature via polymerization of a sol containing compositional precursors [94, 95]. The sol-gel 
process has shown a suitable flexibility in which bioactive glasses could be obtained as 
mesoporous powders, monoliths or nanoparticles [96]. If the sol-gel process performed under 
simple conditions, well-defined mesoporous bioactive glass nanoparticles can be synthesized for 
specific applications such as  anti-bacterial [97] and cancer drug delivery applications [98]. 
Controlled drug delivery is an important strategy for the effective treatment of various 
cancers [99]. Mesoporous bioactive glasses have been recently found as appropriate platforms 
for target-specific drug delivery applications in cancer treatment. One of the merits of these 
materials is that they can be also used in bone repair and regeneration as bone fillers when 
patients suffer from bone cancers that require to remove the part of the bone tissue. As a drug 
carrier, these materials benefit from a couple of advantages such as high biocompatibility and 
appropriate stability with the ability to bond to the living tissues [100]. In order to clarify their 
biocompatibility, Sui et al. [101] evaluated biosafety of drug-loadable mesoporous bioactive glass 
nanospheres in vitro and in vivo. They examined bio-distribution, clearance, cellular location and 
systemic risk of the mesoporous bioactive glasses through 45Ca labeling and histological analysis. 
The results revealed that mesoporous bioactive glass nanospheres could not cause cellular 
damages and histopathological or biochemical indices abnormality. The ability of mesoporous 
bioactive glasses for controlled release of imatinib (IMT), an anti-cancer drug, and its inhibitory 
effects on cancer cells in vitro has been assessed by Shoaib et al. [102]. They successfully loaded 
  
40 
 
IMT into a series of sol-gel prepared mesoporous bioactive glass with the loading efficiency of 
77.59%. The drug loading concentration (0.2-1.0 mg/mL), as well as release kinetics, were 
adjusted by controlling the pH (4.4 to 10.4). They showed that the maximum drug release was 
about 81% during a time period of 250h at a pH of 4.4. Furthermore, in vitro assays confirmed 
that this system was a proper approach having considerable inhibitory effects on the viability of 
the MG-63 osteocarcinoma cancer cells (at 12.19 µg/mL of samples). In another study, Wang et 
al. [103] studied the biological activity and doxorubicin release of mesoporous bioactive glass 
nanospheres. They could successfully load the anticancer drug doxorubicin into the mesoporous 
bioactive glass nanospheres with an encapsulation efficiency of 63.6%. Similar to other 
researchers, they noted that the drug release and encapsulation capability of the mesoporous 
bioactive glass nanospheres could be greatly influenced by the mesoporous structure as well as 
local pH environment. It is expected that this strategy plays an important role in the future of 
different cancers, with the development of innovative applications of mesoporous bioactive 
glasses in the treatment of different hard and soft tissues and organs. 
 
5. Concluding remarks and future perspectives 
Recently, magnetic nanoparticles have appealed much consideration as very favorable 
candidates for an extensive range of applications in cancer treatment [104, 105]. The production 
of magnetic nanoparticles via the glass-ceramic method has also been the focus of many works 
[33]. Along with their well-known benefits, like the ease of preparation and the financial 
concerns, glass-ceramics are also very suitable to obtain controlled microstructures. The glass-
ceramic method has previously been used to synthesize some ferrite nanoparticles like Fe3O4 
and ZnFe2O4 [10, 106]. The most favorable uses of these soft magnetite nanoparticles are in 
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emerging biomedical applications, such the magnetic drug targeting, magnetic separation of 
leukemia cells from the blood, magnetic hyperthermia, and contrast agents in MRI process [107]. 
Lately, several studies showed the application of these magnetic nanoparticles for tissue 
engineering and regenerative medicine, indicating that such stimulations could be also helpful 
for tissue regeneration. In these structures, the magnetic particles attach to the cell membrane 
and upon the use of a magnetic field, activate the membrane and initiate some biochemical 
reactions within the cell, not only upholding the growth of functional bone and cartilage but also 
enhance tissue regeneration [108-110]. One more example is the use of magnetic liposomes 
(lipid vesicles, holding magnetic nanoparticles in their construction either in the lipid bilayer or in 
the aqueous compartment) as “vehicles” for controlled/targeted drug delivery [111]. 
Alternatively, in recent years, there has been a revival of attention in the field of hard magnetic 
particles, such as barium ferrite, synthesized by the glass crystallization method. This technique 
enables the precipitation of nanocrystals in the glass matrix, with a properly narrow crystal size 
distribution. The crystal size can be controlled by the temperature and time of heat treatment. 
Lately, the progress of magnetic bioactive glass-ceramics has received much attention as 
a thermo-seed in hyperthermia treatment of cancer, particularly deep-seated bone tumors. 
Usually, these deep-regional tumors are efficiently heated and destroyed at temperatures 
around 42-45 °C, without the damage of neighboring normal tissues [36]. Although there are still 
major drawbacks to overcome, the proponents of this approach are optimistic, indicating that 
magnetic bioactive glass-ceramics and mesoporous bioactive glasses would be effective to treat 
cancerous cells. It is expected that this class of biomaterials play a critical role even in clinical 
applications. Comprehensive researches in materials science and cellular biology still needed to 
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fully understand the processes involved in the treatment of cancer cells. In addition, future in 
vivo and in vitro studies should systematically assess various effects of glasses and glass-ceramics 
on different cells. Interdisciplinary research and effective collaborations can potentially 
overcome major issues and make this treatment a viable option in the near future. 
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Figures captions: 
Fig. 1. In magnetic hyperthermia, the generated heat mainly originates from eddy currents and 
hysteresis losses. Altering/pulsed magnetic fields are able to induce small electric currents, in 
conducting tissues, proportional to the applied frequency. At very high frequencies, induced 
currents may generate a harmful heat in the tissues. At low frequencies (0–100 KHz), the 
released heat in the tissues is somewhat negligible, but the induced currents, if sufficiently 
strong, can possibly stimulate cells through an electrically stimulation mechanism. (partially 
reprinted with the permission from [20]) 
Fig. 2. (a) Different heat generation mechanisms in magnetic nanoparticles subjected to the 
altering magnetic field. The short straight arrows show the direction of magnetic moment. The 
curved arrows show the movement or change of direction, and the dash lines show the domain 
interfaces in multi-domain magnetic particles. The Néelian relaxation is attributed to the heat 
generated by rotation of discrete magnetic moments in the magnetic particles; whereas the 
Brownian relaxation is attributed to the heat generated by physical rotation of particles 
originating from alignment of magnetic moments with the applied magnetic field. (reprinted 
with the permission from [22]) 
(b) Vascular and cellular effects of hyperthermia on heated tumor tissues. Vascular effects 
comprise increase of blood flow, vascular permeability, and vasodilation. Cellular effects 
comprise DNA repair inhibition, protein denaturation, and upregulation of heat shock proteins. 
(reprinted with the permission from [23]) 
Fig. 3. Magnetic hysteresis loops of (65-x) SiO2, 20(CaO, P2O5), 15Na2O, x (ZnO, Fe2O3) glass-
ceramics as a function of zinc-iron oxide concentration (under a magnetic field strength of ±20 
kOe). (a) An expanded view of hysteresis loops. (b) The initial magnetization curves of the sample 
with 6 and 9 mole% zinc–iron oxide. As can be seen, the required magnetic field to reach the 
saturation value increases with the further addition of zinc–iron oxide content in the glass-
ceramic samples. However, there is no tendency for saturation magnetization for the samples 
with 6 and 9 mole % zinc–iron oxide concentrations even at ±20 kOe (reprinted with permission 
from [84]).  
Fig. 4. Variations of ZnFe2O4 crystallite size versus ZnO content in 25CaO, (40-x) SiO2, 7P2O5, 
3Na2O, xZnO, 25Fe2O3 glass-ceramics and coercivity force at 10 KOe and 500 Oe. As can be seen, 
the crystallite size increases with the further addition of ZnO. In addition, the coercivity values 
increase with crystallite growth of ZnFe2O4. Although coercivity commonly decreases by the 
increase of crystallite size in the multi-domain structures (owing to the facility in rotation of 
domain walls), when the magnetite particle size lies in the range of 10-50 nm, a single domain 
structure is formed which requires an increased coercivity. Since the crystallite size of ZnFe2O4 is 
about 30-58 nm, it can be deduced that a pseudo-single domain structure of ZnFe2O4 crystallites 
is responsible for the increase of coercivity. (reprinted with the permission from [10]) 
Fig. 5. Variation of the magnetic parameters versus composition for magnetically aligned and 
non-aligned 25CaO, (40-x)SiO2, 7P2O5, 3Na2O, xZnO, 25Fe2O3 glass-ceramics, (a) Coercive force, 
(b) Remnant magnetization, and (c) hysteresis area. As can be seen, the variation of magnetic 
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parameters became prominent for x= 8−12 due to the higher amount of ferrimagnetic zinc-
ferrite crystalline phase. (reprinted with the permission from [11]) 
Fig. 6. a) Variation of calorimetric parameters including; a) specific power loss, and b) 
temperature increase versus composition for magnetically aligned and non-aligned 25CaO, (40-
x)SiO2, 7P2O5, 3Na2O, xZnO, 25Fe2O3 glass-ceramics. It is evident that the aligned samples 
present higher amounts of calorimetric parameters compared to the non-aligned samples, 
especially for x = 8 and 10 (reprinted with the permission from [40]). 
Fig. 7. (a) The prepared magnetic apatite/wollastonite glass-ceramic containing chitosan-based 
scaffolds implanted in rabbit (in a 1.5 cm bone defect). The X-ray slice of 12 weeks implanted 
scaffolds indicates that high-density calcified shadow is detectable in the experimental side, but 
not detected in the control side (indicated by the arrow), (b) Bone tissue in control side appears 
as green fluorescence. (c) Histological section of the implanted scaffolds shows that mature bone 
tissue can be detected between muscular tissues, indicating that the proposed magnetic 
bioactive scaffolds could potentially promote the osteogenic capability. (d) Histological section of 
control side indicates immature bone and cartilage tissue between muscular tissues. (reprinted 
with the permission from [71]) 
Fig. 8. Magnetic bioactive glass-ceramics of the SiO2-Na2O-CaO-P2O5-FeO-Fe2O3 multicomponent 
system and its potential applications as magnetic bioactive monoliths, bioactive magnetic 
composites, gallic acid (GA) functionalized glass-ceramics and magnetic bioactive drug carriers. 
(partially reprinted with the permission from [80]) 
 
Statement of Significance: 
Although glass-ceramics have not yet reached their potential in cancer therapy, 
research activity is significantly growing. It has been speculated that this idea 
and the advent of modern glass-ceramics could result in significant future 
advances. Undoubtedly, this strategy needs further investigations and many 
critical questions have to be answered before it can be successfully applied for 
cancer treatment. This paper reviews the current state-of-the-art, starting with 
current products and moving onto recent developments in this field. . According 
to our knowledge, there is a lack of a systematic review on the importance and 
developments of magnetic bioactive glass-ceramics and mesoporous bioactive 
glasses for cancer treatment, and it is expected that this review will be of 
interest to those working in this area.   
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